ABERDEEN-BASED oilfield technology company Brinker is forecasting a big surge in turnover and staff numbers in the next three years.
The firm is on schedule to have turnover of £2million in the current year and this is expected to jump to £7.6million in 2011.
Brinker has more than 20 employees based in the Granite City and this is anticipated to break through the 50 mark in the same period.
The company was developed out of Aberdeen University in 2002 to commercialise its innovative platelet technology for sealing costly and challenging pipeline leaks. The innovation is based on how the human body’s own healing mechanism seals small wounds.
Brinker developed mechanical platelets which, when injected into the flow upstream of a known or suspected leak, are conveyed to the leak vicinity where a combination of pressure and flow causes one or more to stem the leak.
The firm is now aiming to become a leading provider focused on delivering integrity-management services to clients in the North Sea.
Neil Glover, Brinker’s new well-integrity manager, said: “With ageing infrastructure in the North Sea, there is a definitive need for effective integrity-management strategies and the opportunities on our doorstep are increasing. Maximising the efficiency of downhole and subsea systems is critically important. Our products and services are well placed to eliminate costly downtime, reduce repair and maintenance costs, as well as mitigate environmental and safety risks and minimise vessel requirements.
“As a small business . . . we need to focus our efforts where we can have the greatest impact and will get the best returns.”
Last November, Brinker received a £3million cash injection from specialist oil and gas private-equity fund Epi-V. The money, which bought Epi-V a 42% stake in Brinker, was to help to fund growth.